FDA Approves Sulbactam-Durlobactam For Patients With Healthcare-Acquired Bacterial Pneumonia

May 25, 2023

MedPage Today (5/24, Ingram) reports, “The FDA has approved sulbactam-durlobactam (Xacduro) for healthcare-acquired bacterial pneumonia caused by certain strains of Acinetobacter baumannii-calcoaceticus complex (A. Baumannii).” An “intravenous treatment,...